Top Markets
#1 ADO Protocol ADO Protocol +329.39%
#2 GoPlus Security GoPlus Security +52.29%
#3 Nockchain Nockchain +48.47%
#4 The Black Bull The Black Bull +39.67%
#5 Starpower Starpower +34.78%
#6 Tutorial Tutorial +32.63%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.47%
#8 Fake World Assets Fake World Assets +27.22%
#9 GAIB AID GAIB AID +24.67%
#10 Verus Coin Verus Coin +20.20%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Rank in Stocks #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Share Price
$5.60
Market Cap
$8.18M
Change (1 day)
1.45%
Change (1 year)
10.02%
Country
US
Trade CNS Pharmaceuticals, Inc. (CNSP)

Category

Healthcare
Number of shares outstanding for CNS Pharmaceuticals, Inc. (CNSP)
Number of shares outstanding as of August 2026: 0
According to CNS Pharmaceuticals, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for CNS Pharmaceuticals, Inc. (CNSP) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE